After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
West Monroe featured on Benzinga
Date : February 6, 2015

2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

According to Bloomberg data, drug makers announced a record $234 billion in acquisitions last year, nearly triple 2013 volumes.

The year was marked by a string of mega-deals and serial acquirers, from Medtronic's $42.9 billion purchase of medical device manufacturer Covidien multibillion buys of Forest Laboratories and Allergan. Barely a month in to 2015, the industry shows no signs of sweating out the M&A bug.

West Monroe takes a look at the primary drivers behind pharmaceutical and biotech deals in 2014, and what they indicate for M&A over the next twelve months. Click here to view the article as it originally appeared on Benzinga.


Kyle Sarausky Announced As Winner of M&A Advisor's 8th Annual Emerging Leaders
View More
Related News
Author:
Date : April 7, 2017

West Monroe's Will Hinde sat down with ALM Intelligence's Laura Becker to discuss how he works with clients to create value and guide complex, large-scale business transformations.

Industry:
CommunityHealth Recognizes Firm’s Pro Bono Work in Chicago
Author:
Date : April 6, 2017
Industry:
Author:
Date : February 2, 2017
Will Hinde explains how healthcare organizations can best utilize communication technology to improve patients' customer experience via Healthcare Business News.
Industry: